MIC Capital Partners (Public) (US) IM Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DGNR.U
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
|
+$32.6M |
| 2 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$28.1M |
| 3 |
Fox Class A
FOXA
|
+$16.5M |
| 4 |
Elevance Health
ELV
|
+$14.5M |
| 5 |
Howard Hughes
HHH
|
+$4.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Takeda Pharmaceutical
TAK
|
+$12.9M |
| 2 |
Cemex
CX
|
+$3.16M |
| 3 |
Mastercard
MA
|
+$2.94M |
| 4 |
Fox Class B
FOX
|
+$2.26M |
| 5 |
Alibaba
BABA
|
+$1.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.39% |
| 2 | Communication Services | 19.73% |
| 3 | Consumer Discretionary | 18.52% |
| 4 | Materials | 12.79% |
| 5 | Real Estate | 9.51% |
Similar funds
MIC Capital Partners (Public) (US) IM's Q3 2020 Portfolio in Review
As of Q3 2020, MIC Capital Partners (Public) (US) IM held 23 positions worth $341M, up 44% from $237M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
MIC Capital Partners (Public) (US) IM deployed $80.7M of net new capital in Q3 2020, opening 3 new positions and adding to 5 existing holdings. Its largest new stake was Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f: 2,750,000 shares worth $33.7M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 17% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Cemex, an estimated $3.16M trimmed.
- MIC Capital Partners (Public) (US) IM's largest Q3 2020 buy was Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f: 2,750,000 shares worth $33.7M.
- MIC Capital Partners (Public) (US) IM added most to Fox Class A in Q3 2020, an estimated $16.5M increase.
- MIC Capital Partners (Public) (US) IM's biggest Q3 2020 reduction was Cemex, cutting an estimated $3.16M.
- MIC Capital Partners (Public) (US) IM fully exited Takeda Pharmaceutical in Q3 2020, selling an estimated $12.9M.
- MIC Capital Partners (Public) (US) IM's ten largest holdings make up 81% of its $341M portfolio in Q3 2020.
- MIC Capital Partners (Public) (US) IM opened 3 new positions and closed 3 in Q3 2020.
- MIC Capital Partners (Public) (US) IM's portfolio value rose 44% quarter-over-quarter to $341M.
Based on MIC Capital Partners (Public) (US) IM's 13F filing for Q3 2020, filed 13 Nov 2020.